H

Hyphens Pharma International Ltd
SGX:1J5

Watchlist Manager
Hyphens Pharma International Ltd
SGX:1J5
Watchlist
Price: 0.34 SGD -1.45% Market Closed
Market Cap: 105.1m SGD

Profitability Summary

Hyphens Pharma International Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Hyphens Pharma International Ltd

Margins Comparison
Hyphens Pharma International Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
SG
Hyphens Pharma International Ltd
SGX:1J5
105m SGD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
979.6B USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.4B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
276.6B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.7B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.5B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
271.3B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
146.5B USD
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Hyphens Pharma International Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
SG
Hyphens Pharma International Ltd
SGX:1J5
105m SGD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
979.6B USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.4B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
276.6B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.7B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.5B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
271.3B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
146.5B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Hyphens Pharma International Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate